Intramyocardial angiogenic cell precursors in nonischemic dilated cardiomyopathy

Asian Cardiovascular and Thoracic Annals

Volumn 17, Issue 4, 2009, Pages 382-388

  Arom, Kitipan V ^a   Ruengsakulrach, Permyos ^a   Belkin, Michael ^b   Tiensuwan, Montip ^c  

^a Bangkok Heart Hospital   (Thailand)

^b TEL AVIV UNIVERSITY   (Israel)

^c Mahidol University   (Thailand)

Author keywords

Adult stem cells; Cardiomyopathy; Dilated; Heart failure; Hematopoietic stem cell transplantation; Left; Ventricular dysfunction

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; CELL CULTURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH SURVEY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; ADULT STEM CELL; ANGIOGENESIS; CASE CONTROL STUDY; CONVALESCENCE; FEASIBILITY STUDY; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HOSPITALIZATION; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TIME; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; ADULT STEM CELLS; AGED; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CELLS, CULTURED; FEASIBILITY STUDIES; HUMANS; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; QUALITY OF LIFE; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 70350709767     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/0218492309338105     Document Type: Article

References (20)

1. Badorff C, Brandes RP, Popp R, Rupp S, Urbich C, Aicher A, et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003;107:1024-1032 (Pubitemid 36258727)
2. Lunde K, Solheim S, Aakhus S, Arnesen H, Moum T, Abdelnoor M, et al. Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial. Am Heart J 2007;154:710.e1-8 (Pubitemid 47429599)
3. Ohno N, Fedak PW, Weisel RD, Mickle DA, Fujii T, Li RK. Transplantation of cryopreserved muscle cells in dilated cardiomyopathy: effects on left ventricular geometry and function. J Thorac Cardiovasc Surg 2003;126:1537-1548 (Pubitemid 37449184)
4. Seth S, Narang R, Bhargava B, Ray R, Mohanty S, Gulati G, et al. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J Am Coll Cardiol 2006;48:2350-2351 (Pubitemid 44855430)
5. Porat Y, Porozov S, Belkin D, Shimoni D, Fisher Y, Belleli A, et al. Isolation of an adult blood-derived progenitor cell population capable of differentiation into angiogenic, myocardial and neural lineages. Br J Haematol 2006;135:703-714 (Pubitemid 44674083)
6. Huang RC, Yao K, Li YL, Zhang YQ, Xu SK, Shi HY, et al. Transplantation of autologous bone marrow mononuclear cells on patients with idiopathic dilated cardiomyopathy: early results on effect and security. Zhonghua Xin Xue Guan Bing Za Zhi 2006;34:111-113
7. Wang JA, Xie XJ, He H, Sun Y, Jiang J, Luo RH, et al. A prospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy. Zhonghua Xin Xue Guan Bing Za Zhi 2006;34:107-110
8. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 2001;938:221-230 (Pubitemid 32620035)
9. Li X, Yu X, Lin Q, Deng C, Shan Z, Yang M, et al. Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J Mol Cell Cardiol 2007;42:295-303. (Pubitemid 46135597)
10. Yeh ET, Zhang S, Wu HD, Korbling M, Willerson JT, Estrov Z. Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 2003;108:2070-2073 (Pubitemid 37337581)
11. Zhang S, Wang D, Estrov Z, Raj S, Willerson JT, Yeh ET. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation 2004;110:3803-3807 (Pubitemid 40023979)
12. Gruh I, Beilner J, Blomer U, Schmiedl A, Schmidt-Richter I, Kruse ML, et al. No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 2006;113:1326-1334 (Pubitemid 43739454)
13. Koyanagi M, Urbich C, Chavakis E, Hoffmann J, Rupp S, Badorff C, et al. Differentiation of circulating endothelial progenitor cells to a cardiomyogenic phenotype depends on E-cadherin. FEBS Lett 2005;579:6060-6066 (Pubitemid 41546247)
14. Sun Z, Wu J, Fujii H, Wu J, Li SH, Porozov S, et al. Human angiogenic cell precursors restore function in the infarcted rat heart: a comparison of cell delivery routes. Eur J Heart Fail 2008;10:525-533
15. Roura S, Planas F, Prat-Vidal C, Leta R, Soler-Botija C, Carreras F, et al. Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation. Eur J Heart Fail 2007;9:995-1002. (Pubitemid 47451812)
16. Werner L, Deutsch V, Barshack I, Miller H, Keren G, George J. Transfer of endothelial progenitor cells improves myocardial performance in rats with dilated cardiomyopathy induced following experimental myocarditis. J Mol Cell Cardiol 2005;39:691-697 (Pubitemid 41331057)
17. Chu VF, Giaid A, Kuang JQ, McGinn AN, Li CM, Pelletier MP, et al. Thoracic Surgery Directors Association Award. Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures.. Ann Thorac Surg 1999;68:301-308
18. Hou D, Youssef EA, Brinton TJ, Zhang P, Rogers P, Price ET, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005;112(Suppl I):150-156 (Pubitemid 41266667)
19. Arom KV, Ruengsakulrach P, Jotisakulratana V. Intramyocardial angiogenic cell precursor injection for cardiomyopathy. Asian Cardiovasc Thorac Ann 2008;16:143-148 (Pubitemid 351649803)
20. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007;1:39-49. (Pubitemid 46865811)